As the main member of the project team, he participated in the implementation of many applications of the National Natural Fund; As the project undertaker, it was supported by the doctoral program fund of the Ministry of Education, the start-up fund for studying abroad and the interdisciplinary fund of Huazhong University of Science and Technology. Up to now, more than 40 papers have been published in authoritative journals at home and abroad.

As the person in charge, he presided over the major special project of new drug creation 1 of the Ministry of Science and Technology, the "973" plan 1 sub-project, the National Science Fund for Distinguished Young Scholars 1, two key projects of clinical disciplines of the Ministry of Health, the Innovation Team of the Ministry of Education 1 and two general projects of the National Natural Fund.

Published papers 156 (32 journals included in SCI) in the research fields of early diagnosis and targeted therapy of thrombotic diseases and angiogenesis of multiple myeloma, applied for national invention patent 1 item, won two first prizes of scientific and technological progress in Hubei Province as the person in charge, and was nominated by the Ministry of Education for the second prize of scientific and technological progress 1 item.

He has rich experience in the diagnosis and treatment of intractable diseases in internal medicine system such as fever, lymphadenopathy and bleeding causes. He has unique research in hematological malignancies, hemorrhagic diseases and hematopoietic stem cell transplantation.

Editor-in-chief of more than ten academic monographs such as Modern Internal Medicine Therapeutics, Leukemia and DIC.

Good at: leukemia, lymphoma, multiple myeloma, ITP, aplastic anemia, hematopoietic stem cell transplantation.

He is in charge of more than one scientific research project 10, including two national natural science funds, Hubei Provincial Science and Technology Department 1 Innovation Group, Hubei Provincial Health Department 1 key scientific research project, and Wuhan 1 key scientific research project. Won the first prize of scientific and technological progress of Hubei provincial government1; Presided over the development of prenatal screening and diagnosis technology of birth defects, and 20 1 1 was identified as the international advanced level by experts.

More than 80 scientific papers have been published, of which 6 have been included by SCI and EI, and 6 have been published (chief editor or deputy chief editor).

Editorial board of Chinese Journal of Perinatal Medicine, invited reviewer of Journal of Wuhan University (Medical Edition), and editorial board of Medical Herald.